News

Maplebear heads into Q2 earnings with a positive Earnings ESP, backed by marketplace, enterprise and ad growth despite cautious consumer spending.

All three major US stock indexes were up in late-morning trading Tuesday, as investors grew more opt

IQM Quantum Computers (NASDAQ:IQMX) reported its first results as a public company, outlining a growing order backlog, a second-half-weighted revenue outlook and continued investment in superconducting quantum systems for high-performance computing environments. The company began trading on the Nas

IPG Photonics (NASDAQ:IPGP) reported second-quarter 2026 revenue of $279 million, up 11% from a year earlier and representing its third consecutive quarter of double-digit year-over-year sales growth. Revenue exceeded the midpoint of the company’s guidance, while bookings improved and book-to-bill r

Hut 8 (NASDAQ:HUT) reported second-quarter 2026 revenue growth and improved adjusted EBITDA as its compute operations expanded, while management highlighted progress on its AI data center development projects and project-level financing strategy. Revenue rose approximately 81% year over year to $74

Hotchkis & Wiley, an investment management company, released its second-quarter 2026 investor letter for the “Hotchkis & Wiley Mid-Cap Value Fund.” A copy of the letter can be downloaded here. Equity markets posted strong returns in the second quarter of 2026, with the Russell Midcap Index rising 13.8% and the Russell Midcap Value Index returning 13.4%, […]

Zebra Technologies tops second-quarter earnings and revenue estimates as broad-based growth and acquisitions fuel sales, prompting higher full-year 2026 guidance.

Autodesk currently trades at $246.30 per share and has shown little upside over the past six months, posting a small loss of 2.6%. The stock also fell short of the S&P 500’s 7.1% gain during that period.

Bayer tops Q2 estimates as Crop Science and fast-growing drugs offset pressure from patent-expired brands, while reaffirming its 2026 outlook.

POWL's fiscal Q3 earnings and revenues miss estimates, even as record orders and a $2.4 billion backlog strengthen its outlook.

EME's record backlog, AI infrastructure demand and acquisitions are strengthening growth, as it lifts its 2026 revenue and earnings outlook.

Space stocks are surging ahead of SpaceX's first-ever public earnings report, but with prediction markets flagging a 70% chance of a miss and a 911-million-share lockup expiry days away, traders face a tense setup that could cut either way.

Fidelity National tops Q2 EPS estimates as Banking Solutions fuels growth and margins improve, but the company lowers its full-year revenue and earnings outlook.

Block heads into the Q2 earnings release with 20% gross profit growth targeted, Cash App and Square momentum, and bitcoin volatility shaping the outlook.

Pfizer beats Q2 earnings and revenue estimates, raises the low end of its 2026 sales outlook, but lowers expectations for COVID product revenues.

Pharmaceutical company AbbVie (NYSE:ABBV) reported Q2 CY2026 results exceeding the market’s revenue expectations, with sales up 10.2% year on year to $16.99 billion. Its non-GAAP profit of $3.65 per share was 1.2% above analysts’ consensus estimates.

BWXT raises its 2026 outlook as stronger operations support higher guidance, while a medical divestiture and PCG deal sharpen its nuclear focus.

PHIN misses Q2 earnings estimates despite higher sales as employee costs and product mix weigh on margins.

XOM's Q2 earnings missed estimates, but strong production, oil prices and balance sheet strength support its outlook.

Avis Budget's Q2 earnings miss exposed soft rental demand, while fleet cuts, record utilization and reaffirmed 2026 EBITDA guidance supported margins.

An analysis of the last seven years of Tesla earnings calls shows just little attention Musk pays to Tesla's car business.

NRG's Q2 earnings miss estimates, but revenues climb 11% as lower operating costs and shareholder returns support performance.

Free cash flow is negative while the cloud build runs, and that is the whole question for anyone weighing the stock today.

ODFL's earnings beat, pricing power and strong balance sheet support momentum, but its premium valuation leaves little room for execution missteps.

There have been several standouts in the cycle so far, including Microsoft, Bloom Energy, and EMCOR Group, all of which have seen nice momentum in the days following their robust earnings releases.

Paul Mueller's Q2 revenues jump 29% y/y, but lower margins weigh on earnings as strong pharmaceutical demand and a healthy backlog support the results.

DDOG heads into Q2 with strong momentum as AI products, platform expansion and a strategic acquisition support growth ahead of earnings.

Analysts’ expectations for a sharp year over year jump in earnings and revenue at EOG Resources (EOG) ahead of its upcoming quarterly report have put the stock in focus, even after a recent consensus EPS trim. See our latest analysis for EOG Resources. EOG Resources’ recent momentum is clear, with the share price up 11.39% over the past 30 days and a 35.81% year to date share price return. Meanwhile, the 5 year total shareholder return of 168.41% highlights how longer term holders have been...

TransMedics Group (TMDX) heads into a busy early August, with Q2 2026 results and an earnings call scheduled for August 4 after the market close, drawing fresh attention to the stock. See our latest analysis for TransMedics Group. Recent trading in TransMedics Group reflects this renewed attention, with a 1 day share price return of 6.6% and a 30 day share price return of 18.4%, even as the year to date share price return is down 33.5% and the 1 year total shareholder return is down 35.1%...

FISV's Q2 earnings results are set for Aug. 6, with revenues and profit expected to fall y/y amid weaker financial solutions and rising investment costs.